Case report
An 89-year-old male with chronic myeloid leukemia (CML) was referred with new onset RE pain and severe reduction of vision 1 week after admission for his CML. He was febrile (39 1C), anemic, and presented generalized malaise. He had bilateral age macular degeneration (AMD) that was worse in the RE. On examination there was RE proptosis with limited lateral gaze, significant pain with retropulsion, right eyelid erythema and swelling, chemosis, and purulent discharge (Figure 1a ). Visual acuity (VA) was light perception in the RE and 6/9 in the LE. The intraocular pressures were 34 mm Hg in the RE and 17 mm Hg in the LE. Fundoscopy revealed a RE ERD with shifting fluid, in the absence of PVD or retinal tears.
On full blood count there was neutrophilic leucocytosis (WBC 22.79 Â 10 3 /ml; 94.2% neutrophils). C-reactive protein was 128 mg/l and ESR 106 mm/h. Culture of nasal aspirates revealed methicillin staph aureus (MRSA) and Warneri-Staph.
The patient was placed on intravenous (vancomycin, cefurixime, and metronidazole) and topical antibiotics. Symptoms improved by the fifth post-treatment day and blood tests gradually normalized. Complete resolution of the ERD was evident (Figure 1b) . VA improved to 6/36.
Comment
Orbital cellulitis is an extremely rare cause of ERD. The only published reports 4, 5 refer to a 12-year-old boy who sustained ERD due to orbital cellulitis originating from an eyelid abscess and a 56-year-old with Down's syndrome; the source of infection remained unclear. In our case the MRI findings and the purulent nasal discharge were consistent with ethmoid sinusitis leading to cellulitis. The bacteria responsible for causing the infection are MRSA as the patient was hospitalized, and the nasal aspirate cultures were positive for MRSA. In all cases including ours treatment of cellulitis was followed by rapid resolution of the ERD.
Our case illustrates the uncommon but possible occurrence of ERD in the course of orbital cellulitis. Although the incidence is rare, it may pose diagnostic and therapeutic dilemmas, but it should be considered, especially in immunocompromised patients. Our case illustrates that medical management with strong antibiotics can lead to resolution without surgical intervention even in the presence of sinusitis.
Sir, Liver failure following antituberculosis (ATT) chemotherapy for presumed tuberculous uveitis
We read with great interest the paper by Manousaridis et al, 1 which adds to the publication by Sanghvi et al, 2 with respect to presumed tuberculous (TB) uveitis in the United Kingdom, and we would commend both sets of authors for these well-presented case series. In the latter 2 it was recommended that a full 6-month course of Anti-TB therapy (ATT) be commenced in all patients with uveitis and latent TB, in whom other causes of uveitis have been ruled out. We present a case of acute liver failure secondary to ATT in one such patient.
Case report
A 41-year-old Indian lady presented to Leicester Royal Infirmary Eye Casualty with gradual reduction in vision with floaters and was found to have bilateral granulomatous pan-uveitis. The best-corrected visual acuity was 6/36 in both eyes, and there were multiple choroidal tubercles (Figure 1 ) with leakage on fluorescein angiography. Quantiferon-TB gold testing was positive.
The Infectious Diseases Unit found no evidence of other active systemic TB and the patient was started on Rifater (rifampicin, isoniazid, pyrazinamide), Moxifloxacin 400 mg, and Pyridoxine 10 mg. After 28 days, the patient was admitted to a tertiary liver centre ITU with acute liver failure presumed secondary to ATT and subsequently developed severe autoimmune haemolysis presumed secondary to rifampicin. The ATT was stopped and the patient recovered. The patient declined any further ATT. The visual acuity at her last visit was 6/9 in each eye with low-dose topical steroid.
Comment
Hepatotoxicity is the most common iatrogenic disease in TB 3 with an incidence between 1 and 10% worldwide, 4, 5 and 4% in the United Kingdom. 6 The benefits of ATT clearly outweigh the risks for active TB. However, this is not true in cases of latent TB and NICE guidance highlights those patient groups most likely to benefit from ATT. 7 In the series of patients reported, 1,2 those who benefited most in terms of visual acuity from ATT had 
